You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial

Article metrics

Article menu
Health economics
Original research
Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial

 

Online download statistics by month:

Online download statistics by month: September 2022 to November 2024

AbstractFullPdf
Sep 202289490094
Oct 202243944260
Nov 202234832945
Dec 202236836129
Jan 202338136160
Feb 202326225749
Mar 202310810441
Apr 2023767138
May 2023595639
Jun 2023929137
Jul 2023767432
Aug 2023625415
Sep 2023877547
Oct 2023798035
Nov 2023948246
Dec 2023858030
Jan 2024886740
Feb 2024747230
Mar 2024807874
Apr 2024969045
May 2024706329
Jun 2024737040
Jul 2024978933
Aug 2024574717
Sep 2024686536
Oct 2024918747
Nov 2024918727
Total439542321115